Toxicokinetics in preclinical evaluation
Related Experiment Video
Updated: Sep 27, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
1Consultancy and Regulatory Services, Covance Laboratories, Harrogate, UK. paul.baldrick@covance.com
Abstract:
Toxicokinetic evaluation is both a regulatory and scientific requirement in the drug development process. However, as a fairly new term, its use within the industry is still confused. Toxicokinetics is the generation of kinetic data to assess systemic exposure, either as an integral component of preclinical toxicity studies, or in specially designed supportive studies. These data help to understand the relationship between observed toxicity and administered dose. They also play a role in the clinical setting, assisting in the setting of plasma limits for early human exposure and in the calculation of safety margins.
More Related Videos
Related Concept Videos
Toxicokinetics: Overview
Toxicity Testing in Animals
Preclinical Development: Overview
Drug Toxicity: Dose-Dependent Reactions
Measurement of Bioavailability: Pharmacokinetic Methods
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...

